Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle (Q53245657)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 14, 2011

Language	Label	Description	Also known as
English	Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle	scientific article published on May 14, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle (English)

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

0 references

author name string

Toshihiro Yamamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Yugo Habata

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Yoshio Matsumoto

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Yoshitaka Yasuhara

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Tadatoshi Hashimoto

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Hitomi Hamajyo

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Hisashi Anayama

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Ryo Fujii

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Hiromitsu Fuse

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Yasushi Shintani

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Masaaki Mori

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21609753

3 December 2024

publication date

14 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

number of pages

10

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0304416511001073?httpAccept=text/xml

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

https://api.elsevier.com/content/article/PII:S0304416511001073?httpAccept=text/plain

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

1810

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

853-862

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

1

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Molecular properties of apelin: tissue distribution and receptor binding

2

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

The apelinergic system: a promising therapeutic target

3

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis

4

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Retardation of retinal vascular development in apelin-deficient mice

5

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis

6

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin increases contractility in failing cardiac muscle

7

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

The emerging role of adipokines as mediators of inflammation and immune responses

8

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice

9

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

10

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin, a newly identified adipokine up-regulated by insulin and obesity

11

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse

12

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia

13

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin is necessary for the maintenance of insulin sensitivity

14

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

15

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice

16

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum

17

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Immunohistochemical Differentiation of Fiber Types in Human Skeletal Muscle Using Monoclonal Antibodies to Slow and Fast Isoforms of Troponin I Subunit

18

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Endothelial-mural cell signaling in vascular development and angiogenesis

19

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels

20

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation

21

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans

23

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

The effects of apelin treatment on skeletal muscle mitochondrial content

24

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

25

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

26

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.

27

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people

28

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus

29

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma

30

1 reference

10.1016/J.BBAGEN.2011.05.004

https://api.crossref.org/works/10.1016/J.BBAGEN.2011.05.004

3 December 2024

Identifiers

10.1016/J.BBAGEN.2011.05.004

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21609753

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53245657&oldid=2282910389"